As antibody-drug conjugates (ADCs) continue to advance through clinical development and commercialization, regulatory expectation increasing for process understanding and manufacturing consistency have become increasingly rigorous. For ADC developers, process characterization and process validation are not only simply regulatory requirements but also critical activities that establish process robustness, product quality, and long-term manufacturing reliability.
Understanding these activities also helps evaluate whether a development partner has sufficient technical depth required to support scale-up and commercialization.
What Is ADC Drug Substance Process Characterization and Validation?
ADC drug substance process characterization is the systematic study of manufacturing processes to understand how process parameters affect product quality. The goal is to identify critical process parameters (CPPs), understand their relationship to critical quality attributes (CQAs), and establish a robust manufacturing control strategy.
Process validation builds on this knowledge by demonstrating that the manufacturing process can consistently produce material meeting predefined quality specifications.
Process characterization defines how process parameters impact product quality, while process validation confirms consistent performance under manufacturing conditions.
Why Process Characterization Matters
ADC manufacturing involves a unique combination of biologics production, linker-payload chemistry, conjugation technology, and analytical characterization. Small variations in process conditions can significantly affect product quality attributes in ADC manufacturing.
A comprehensive characterization program helps manufacturers:
• Understand process variability
• Identify critical quality risks
• Establish appropriate control strategies
• Support process scale-up and technology transfer
• Facilitate regulatory submissions
For ADCs, this is particularly important because attributes such as drug-to-antibody ratio (DAR), aggregation levels, free payload content, and product heterogeneity can directly impact safety and efficacy.
Key Elements of ADC Process Characterization
Several studies are typically included in ADC process characterization:
Conjugation Process Understanding
The conjugation step is often the most critical stage in ADC manufacturing. Studies evaluate factors affecting DAR distribution, payload loading, reaction efficiency, and product homogeneity.
Critical Process Parameters (CPPs)
Common critical process parameters (CPPs) include:
• pH
• Temperature
• Reaction time
• Antibody-to-payload ratio
• Mixing conditions
These parameters are evaluated to establish acceptable operating ranges.
Critical Quality Attributes (CQAs)
Typical critical quality attributes (CQAs) for ADC drug substances include:
• Drug-to-antibody ratio (DAR) & DAR distribution
• Aggregation
• Purity
• Free payload content
• Biological activity
Robustness, Hold-Time, and Scale-Up Studies
Additional studies assess process robustness, intermediate stability, and manufacturing performance during scale-up or technology transfer.
How Process Validation Builds on Process Characterization
Once process understanding has been established, validation studies demonstrate manufacturing consistency under defined operating conditions.
Typical validation activities include:
• Process Performance Qualification (PPQ)
• Batch consistency evaluation
• Analytical method validation
• Cleaning validation
• Continued process verification
Together, these studies provide documented evidence that the process can consistently deliver product meeting predefined specifications.
What to Look for in an ADC Process Characterization and Validation Partner
When evaluating an ADC development partner, companies should look for expertise in:
• Conjugation process development
• CPP and CQA assessment
• Advanced analytical characterization
• Formulation development support
• Process scale-up and technology transfer
ChemExpress supports ADC development through integrated capabilities spanning process development, analytical characterization, formulation development, and manufacturing support, helping sponsors establish scalable and well-characterized manufacturing processes.